| Dr David Forshaw, MD | |
|
500 Chase Pkwy, Waterbury, CT 06708-3346 | |
| (203) 755-6677 | |
| Not Available |
| Full Name | Dr David Forshaw |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 20 Years |
| Location | 500 Chase Pkwy, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437353182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 49586 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Mary's Hospital | Waterbury, CT | Hospital |
| Griffin Hospital | Derby, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurosurgery Orthopaedics And Spine Specialists Pc | 8820087463 | 15 |
News Archive
People that suffer from health anxiety (Hypochondriacs) use very much of their time and energy on checking whether or not they have a serious disease.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF).
Neighborhood factors do not influence the use of emergency medical services (EMS) for stroke as strongly as individual factors do, despite earlier indications that socio-demographic characteristics of the neighborhood explain low rates of EMS activation for this life-threatening emergency.
› Verified 8 days ago
| Entity Name | Neurosurgery Orthopaedics & Spine Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831359215 PECOS PAC ID: 8820087463 Enrollment ID: O20040510000696 |
News Archive
People that suffer from health anxiety (Hypochondriacs) use very much of their time and energy on checking whether or not they have a serious disease.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF).
Neighborhood factors do not influence the use of emergency medical services (EMS) for stroke as strongly as individual factors do, despite earlier indications that socio-demographic characteristics of the neighborhood explain low rates of EMS activation for this life-threatening emergency.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Forshaw, MD 500 Chase Pkwy, Waterbury, CT 06708-3346 Ph: (203) 755-6677 | Dr David Forshaw, MD 500 Chase Pkwy, Waterbury, CT 06708-3346 Ph: (203) 755-6677 |
News Archive
People that suffer from health anxiety (Hypochondriacs) use very much of their time and energy on checking whether or not they have a serious disease.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF).
Neighborhood factors do not influence the use of emergency medical services (EMS) for stroke as strongly as individual factors do, despite earlier indications that socio-demographic characteristics of the neighborhood explain low rates of EMS activation for this life-threatening emergency.
› Verified 8 days ago
Alan S. Waitze, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-573-1982 | |
Dr. Jarob N Mushaweh, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-755-7166 | |
Stephen A. Torrey, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-755-7166 | |
Michael E. Karnasiewicz, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Chase Pkwy, Suite 2a, Waterbury, CT 06708 Phone: 203-755-6677 Fax: 203-573-9182 |